Header Logo

Connection

WILLIAM DECKER to Receptors, CCR4

Back to Details
This is a "connection" page, showing publications WILLIAM DECKER has written about Receptors, CCR4.
WILLIAM DECKER
Connection Strength
0.030
Receptors, CCR4
  1. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome. Clin Cancer Res. 2015 Jan 15; 21(2):274-85.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.